The Sherwin-Williams Company, listed on the New York Stock Exchange under the symbol SHW, has received an average recommendation of “Moderate Buy” from nineteen brokerages currently covering the company, according to Bloomberg Ratings. Out of these analysts, five have recommended holding the stock, while fourteen have given it a buy recommendation. Furthermore, these brokerages have established an average 1-year price objective for SHW at $283.61.
On Friday, September 22, 2023, NYSE:SHW opened at a price of $254.29. The company’s stock has demonstrated a 50-day simple moving average of $270.82 and a 200-day simple moving average of $246.54. Currently, Sherwin-Williams boasts a market capitalization of $65.39 billion with a price-to-earnings (P/E) ratio of 28.22. The stock’s price-to-earnings-growth (PEG) ratio stands at 2.17 and its beta is reported at 1.10.
In terms of liquidity ratios, Sherwin-Williams possesses a current ratio of 1.00 and a quick ratio of 0.62 showing that the company has sufficient assets to cover short-term obligations adequately. Additionally, the specialty chemicals company has a debt-to-equity ratio of 2.50.
Over the past year, SHW has reached its lowest point at $195.24 and its highest point at $283.80.
Numerous institutional investors and hedge funds have recently made purchases or sales involving shares of SHW as well. Wealth Alliance witnessed an increase in its stake in Sherwin-Williams by approximately 119.5% during the fourth quarter and now holds 2,472 shares worth around $587,000 after acquiring an additional 1,346 shares during that period.
Aureus Asset Management LLC experienced a slight uptick of 0.9% in its holdings of Sherwin-Williams shares, resulting in ownership of 132,579 shares worth approximately $31.46 million.
During the first quarter, Atria Investments Inc. increased its position in SHW by 5.6%, now owning 27,723 shares valued at around $6.23 million.
Meanwhile, RMB Capital Management LLC grew its stake in Sherwin-Williams by 18.9% during the same period and now holds 1,861 shares valued at about $418,000.
Lastly, Hudson Valley Investment Advisors Inc. ADV rounded off these institutional investments with a boost of 39.8% in the first quarter. The firm owns 20,645 shares of Sherwin-Williams stock worth approximately $4.64 million.
In regard to earnings data, Sherwin-Williams released its quarterly report on July 25th. During that period, the company reported earnings per share (EPS) of $3.29, surpassing the consensus estimate of $2.71 by $0.58. Furthermore, Sherwin-Williams achieved revenues of $6.24 billion for the quarter compared to analyst predictions of $6.03 billion.
Sherwin-Williams demonstrated a return on equity (ROE) of 83.63% and a net margin of 10.20%, indicating profitability within the company’s operations for the given quarter.
In comparison to the same quarter last year, Sherwin-Williams experienced a revenue growth of 6%. In that previous quarter, the company posted earnings per share (EPS) amounting to $2.-41
Research analysts are projecting that for this current fiscal year ending on an unspecified date later this year; Sherwin-Williams will record earnings per share (EPS) totaling approximately $9.-78.
Becton, Dickinson and Company
BDX
Strong Buy
Updated on: 05/12/2023
Financial Health
Very Healthy
Debt to equity ratio: Buy
Price to earnings ratio: Strong Buy
Price to book ratio: Strong Buy
DCF: Strong Buy
ROE: Neutral
Market Experts Show Confidence in Sherwin-Williams Shares with Upward Price Adjustments and Positive Ratings
In a recent report published on Wednesday, July 26th, Mizuho portfolio managers upped their price target of Sherwin-Williams shares from $290.00 to $305.00. This upward adjustment in the price target reflects positive sentiments towards the company’s performance and prospects for growth in the near future.
Further support for Sherwin-Williams comes from a research report issued by StockNews.com on Thursday, August 17th. The report initiated coverage on Sherwin-Williams shares and assigned a “buy” rating to the stock. This signifies that analysts believe the stock is undervalued and has great potential for appreciation.
Barclays also weighed in on Sherwin-Williams in a research report dated Tuesday, July 25th. They boosted their price objective from $240.00 to $285.00, signifying confidence in the potential upside for investors in this particular equities investment option. However, they maintained an “equal weight” rating, indicating that while they see opportunities for growth, they do not believe it significantly outperforms its competitors.
Renowned financial services firm Robert W. Baird concurred with the optimistic outlook for Sherwin-Williams in their report issued on Wednesday, July 26th. They raised their target price from $275.00 to $300.00, suggesting that there is substantial room for growth within this equity option.
Adding to this growing chorus of positive outcries, Royal Bank of Canada lifted their price target on Sherwin-Williams shares from $272.00 to $315.00 on Wednesday, July 26th as well—a significant boost that reflects high hopes for the company’s future earnings potential.
It is important to note that Sherwin-Williams recently announced a quarterly dividend payment which was disbursed on Friday, September 8th—providing additional incentives to shareholders who hold onto their positions during this time period. Investors of record on Friday, August 18th received a dividend payment of $0.605 per share. The ex-dividend date, which signifies the cutoff point for excluding new investors from receiving the latest dividend, was set for Thursday, August 17th.
The annualized dividend for Sherwin-Williams stands at $2.42 per share, resulting in a yield of 0.95%—a notable return for long-term shareholders seeking stable income streams.
Sherwin-Williams’s payout ratio—the percentage of earnings paid out as dividends—is currently at 26.86%. This indicates that the company is committed to creating value for its investors by sharing a significant portion of its earnings through regular dividends.
Overall, industry analysts and market experts are displaying an overwhelmingly positive sentiment towards Sherwin-Williams shares. With multiple research reports raising price targets and initiating coverage with a “buy” rating, it is evident that this company has managed to capture investor attention and instill confidence in its ability to deliver steady growth and shareholder value. As always, investors should conduct thorough research before making any investment decisions to ensure alignment with their own investment strategies and risk appetite.
(Article Reference Date: September 22, 2023)
Discussion about this post